How Healthcare Organizations Can Securely Adopt AI Agents

Last updated: June 15, 2026

To securely adopt AI agents in healthcare and life sciences, scope each agent’s access to protected health information, govern its tool calls into clinical systems through one enforcement point, test it before it reaches patients, and inspect every interaction at runtime. Healthcare adds a patient-safety dimension: an agent can act on the electronic health record, not just read it. (Health-ISAC, 2026)

How are healthcare and life sciences organizations using AI agents?

Healthcare AI use is moving into agentic workflows, even as governance lags, according to a 2026 peer-reviewed review in npj Digital Medicine (npj Digital Medicine, 2026). Health systems are deploying agents for scheduling, prior authorization, clinical documentation, patient communication, and claims, while life sciences teams use them for clinical-trial operations and drug discovery.

Agents in these settings do not just answer questions. They read and write to the electronic health record (EHR), imaging archives, and scheduling systems, and they act on patient data. In a 2026 Forrester Consulting study of 450 United States healthcare organizations, security risks were the top hesitation about adopting agentic AI, cited by 78%, ahead of skills gaps at 69% (Forrester Consulting, 2026). Adoption is climbing, but the controls to govern these agents have not kept pace.

Why is securing AI agents harder in healthcare and life sciences?

Healthcare is the costliest sector for data breaches, averaging $7.42 million per incident in 2025, the highest of any industry for 14 straight years (IBM, 2025). Agents raise the stakes: they hold live access to electronic health records and patient data, and a failed or compromised agent can disrupt care, not only leak records.

Healthcare runs on blended environments where clinical, administrative, and third-party systems connect, and protected health information (PHI) is among the most valuable data on the dark web. Breaches in the sector also take the longest to contain, 279 days on average (IBM, 2025). The threat is rising: in a November 2025 Health-ISAC survey, executives and security professionals ranked AI-enabled attacks the top concern for 2026 (Health-ISAC, 2026).

What are the main agentic AI risks for healthcare and life sciences?

The main agentic AI risks in healthcare are protected health information (PHI) exposure, prompt injection, over-permissioned agents reaching clinical systems, shadow agents on clinician devices, and unsafe outputs that affect patient safety. Health-ISAC warns that over-permissioned accounts and credential misuse are amplified by AI-enabled workflows (Health-ISAC, 2026).

Six failure modes show up most often when clinical agents are deployed without controls:

Agentic AI risk in healthcare What can go wrong
PHI exposure An agent with access to electronic protected health information (ePHI) sends it to a public AI tool, a third-party model, or another agent.
Prompt injection in clinical content Hidden instructions in a document, portal message, or record steer a clinical agent off task, including toward data exfiltration. OWASP ranks prompt injection as the top entry in its Top 10 for Large Language Model Applications (OWASP, 2025).
Over-permissioned agents Agents get broad EHR, imaging, and scheduling access at setup and rarely give it back. IBM found 97% of AI-related breaches hit organizations lacking proper AI access controls (IBM, 2025).
Shadow agents on clinician devices Staff connect agents and Model Context Protocol servers without IT’s knowledge, including agents on personal or work devices that can reach patient data.
Unsafe or false clinical outputs An agent returns wrong clinical information or takes a wrong action, which is a patient-safety risk, not only a data risk.
Care disruption A rogue or failed agent interrupts the systems clinicians depend on, slowing care and increasing the chance of errors.

What do healthcare AI regulations require for AI agents?

Healthcare AI agents fall under existing rules. Any agent that can reach protected health information (PHI) is in scope for the Health Insurance Portability and Accountability Act (HIPAA), which requires access control, logging, and protection against unauthorized disclosure. In June 2026, the Health Sector Coordinating Council issued guidance for governing AI, including agentic AI, in clinical settings (AHA, 2026).

These obligations map directly onto how an agent is governed:

Regulation or framework What it means for AI agents
HIPAA Privacy and Security Rules Any agent that can reach PHI is in scope. You must control its access, log its use, and prevent disclosure to unauthorized parties or public AI tools.
Proposed HIPAA Security Rule update The proposed update tightens requirements such as asset inventory and network mapping, which means knowing every agent that touches electronic PHI and where it runs, including on endpoints.
FDA oversight of AI-enabled medical devices Agents embedded in or acting on regulated software as a medical device fall under expectations for safety, validation, and change control.
HITECH and breach notification A PHI disclosure caused by an agent is a reportable breach, with notification duties and potential penalties.
Life sciences data and IP protection Clinical-trial data, research, and drug-discovery intellectual property are high-value targets, so agents touching them need the same least-privilege and audit controls.

Sector guidance points the same way. A Health-ISAC working-group white paper prohibits exposing PHI to public AI tools and requires human review of AI outputs in clinical, legal, and financial contexts (Health-ISAC, 2026).

How to securely adopt AI agents in healthcare: a control checklist

Adopt clinical AI agents the way 2026 Five Eyes guidance recommends: start with low-risk tasks, raise access and autonomy gradually, and treat governance, human oversight, and accountability as requirements, not options (CISA, 2026). In practice, that is six controls, and least privilege to PHI comes first.

Health-ISAC recommends governing AI agents as “digital workers” with defined ownership, monitoring, logging, and approved use cases (Health-ISAC, 2026). These six controls put that into practice:

Control What to do in a healthcare or life sciences environment
Discover every agent, including on clinician endpoints Inventory agents in Commercial AI tools, agents embedded in clinical software as a service (SaaS) apps, and agents running locally on employee devices, including any that can reach PHI.
Scope each agent to least privilege Give every agent task-specific access to ePHI and short-lived credentials, and remove standing privileges across EHR, imaging, and scheduling systems.
Govern Model Context Protocol tool calls Treat the Model Context Protocol (MCP) as an access channel into clinical systems and check every tool call against policy before it runs.
Test before deployment Stress clinical agents with adversarial prompt injection and jailbreak attempts, and match generated code against known vulnerabilities (CVEs).
Govern outputs and data at runtime Inspect every prompt and response, block unsafe clinical outputs, and track PHI as it moves across tool calls.
Keep one audit trail for HIPAA Log every interaction so you can answer what an agent did, on whose behalf, and under which policy, which supports breach investigation and compliance.

How do approaches to securing AI agents compare in healthcare?

Identity tools, network tools, and AI-native controls cover different parts of agent risk in a clinical environment. Identity tools confirm who an agent is. Network tools see where traffic goes. Neither inspects the protected health information flowing through prompts, responses, and tool calls. A dedicated AI-native control layer adds that visibility and works alongside the HIPAA controls you already run. (Aurascape, 2026)

Identity-first and network-first tools each cover part of the problem. Here is how the approaches compare for healthcare and life sciences:

Capability Identity-first and network-first tools Aurascape
Discovering agents that touch PHI on clinician devices Identity tools track issued credentials; network tools see traffic. Neither reliably finds agents running locally on a clinician’s laptop. Discovers AI agents running locally on endpoints, including agents that can reach PHI, plus agents in Commercial AI and embedded in clinical SaaS apps.
Seeing prompts, responses, and tool calls into the EHR See who an agent is or where its traffic goes, not the PHI flowing through the interaction. Full visibility into prompts, AI model responses, and every tool call across both agent channels, with sensitive-data detection.
Governing MCP tool calls into EHR, imaging, and scheduling systems Often out of scope, or limited to policy on credentials. Zero-Bypass MCP Gateway signs approved tool calls and blocks unsigned ones, with fail-closed enforcement.
Stopping PHI leakage and unsafe clinical outputs in real time Typically logged after the fact. Inspects and gates outputs with Safe Output Governance and tracks PHI across chained tool calls.
Testing clinical agents before deployment Not a focus. Runs adversarial guardrail tests and code-path vulnerability checks before an agent reaches patients.
Fit with HIPAA controls and existing stack The tool itself is the control. Adds a control layer at the point of AI interaction that complements identity, network, DLP, and code-security tools, with one audit trail.

How Aurascape secures agentic AI in healthcare and life sciences

Aurascape secures clinical AI agents at the point of interaction, across both channels an agent uses. The AI Proxy inspects the Intelligence Channel between the agent and the AI model. The Zero-Bypass MCP Gateway governs the Tool Execution Channel into EHR, imaging, and scheduling systems, signing approved tool calls and blocking unsigned ones. Aurascape also discovers AI agents running locally on clinician endpoints. (Aurascape, 2026)

Aurascape works across three stages, for the agents clinical and research teams use and the agents they build, as detailed in its whitepaper (Aurascape, 2025):

Stage What Aurascape does
See Discover every agent and private AI app, including agents running locally on clinician endpoints, map every MCP server and tool they reach into clinical systems, and separate sanctioned from unsanctioned. Cross-call data lineage tracks PHI as it moves.
Test Before an agent ships, evaluate it against prompt injection, jailbreak, code injection, and false outputs, and execute its code paths to catch vulnerabilities and CVE matches.
Protect At runtime, the Zero-Bypass MCP Gateway secures tool calls and the AI Proxy secures model interactions, with Safe Output Governance gating outputs and one audit trail recording every action.

Endpoint discovery matters in healthcare because an agent on a clinician’s laptop can hold read and write access to the EHR and patient data. Without endpoint-level discovery, an undiscovered agent on a clinical device stays invisible to network-only and identity-only tools. Aurascape requires agent traffic to pass through its AI Proxy, and offers flexible deployment to route it there. Aurascape adds this control layer alongside your identity, network, and code-security tools rather than replacing them. The live capabilities are described on the Secure Agentic AI page (Aurascape, 2026).

Frequently asked questions

Is agentic AI HIPAA compliant?

Agentic AI is not automatically HIPAA compliant. Compliance depends on how an organization controls an agent’s access to protected health information (PHI), logs its activity, and prevents unauthorized disclosure. Any agent that can reach PHI is in scope, so the controls around it, not the technology itself, determine compliance. Sector guidance specifically prohibits exposing PHI to public AI tools. (Health-ISAC, 2026)

What are the main risks of AI agents in healthcare?

The main risks are PHI exposure, prompt injection, over-permissioned agents reaching clinical systems, and unsafe outputs that affect patient safety. Healthcare adds a dimension that other sectors do not face as sharply: an agent can disrupt care or take a clinically unsafe action, not only leak data. (Health-ISAC, 2026)

How do I discover AI agents touching patient data?

Discover them through a combination of endpoint and network visibility. Agents can run inside Commercial AI tools, sit embedded in clinical software as a service (SaaS) apps, or run locally on clinician devices with access to PHI. Aurascape discovers AI agents running locally on endpoints alongside network-based discovery, so agents with read and write access to patient data do not stay hidden. (Aurascape, 2026)

Can AI agents be used safely with electronic health records?

Yes, when access is scoped and every interaction is governed. An agent connected to an electronic health record (EHR) should have least-privilege access, route its tool calls through one enforcement point, and have its outputs inspected before they reach clinicians or patients. (Aurascape, 2026)

AI agents in healthcare and life sciences act on real patient data and real clinical systems. Securing them is a matter of seeing what is running, scoping access to PHI, governing tool calls into clinical systems, and watching every interaction. Aurascape gives security teams that visibility and control, so providers and life sciences organizations can adopt AI agents with confidence.

Start with the pillar guide, How to Securely Adopt AI Agents, review AI compliance frameworks for healthcare and pharmaceutical organizations, see how to secure AI coding assistants in healthcare and life sciences, or learn how to prevent AI data leakage. To see Aurascape on your own environment, book a demo.

Aurascape Solutions